Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CureVac N.V (CVAC) Enterprise Value: 2019-2025

Historic Enterprise Value for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to $774.6 million.

  • CureVac N.V's Enterprise Value rose 43.30% to $774.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$818.5 million, marking a year-over-year decrease of 11.43%. This contributed to the annual value of $246.3 million for FY2024, which is 51.40% down from last year.
  • Latest data reveals that CureVac N.V reported Enterprise Value of $774.6 million as of Q2 2025, which was up 395.27% from $156.4 million recorded in Q1 2025.
  • In the past 5 years, CureVac N.V's Enterprise Value ranged from a high of $15.2 billion in Q1 2021 and a low of -$1,619.1 billion during Q2 2021.
  • Over the past 3 years, CureVac N.V's median Enterprise Value value was $523.7 million (recorded in 2024), while the average stood at $604.4 million.
  • Per our database at Business Quant, CureVac N.V's Enterprise Value crashed by 17,404.28% in 2021 and then surged by 100.12% in 2022.
  • CureVac N.V's Enterprise Value (Quarterly) stood at $5.5 billion in 2021, then crashed by 88.38% to $637.0 million in 2022, then decreased by 20.43% to $506.8 million in 2023, then tumbled by 51.40% to $246.3 million in 2024, then soared by 43.30% to $774.6 million in 2025.
  • Its Enterprise Value stands at $774.6 million for Q2 2025, versus $156.4 million for Q1 2025 and $246.3 million for Q4 2024.